Previous Close | 107.32 |
Open | 108.53 |
Bid | 90.00 x 900 |
Ask | 110.00 x 1000 |
Day's Range | 108.34 - 109.98 |
52 Week Range | 30.17 - 127.19 |
Volume | 26,918 |
Avg. Volume | 871,759 |
Market Cap | 9.406B |
Beta (5Y Monthly) | 1.31 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -2.84 |
Earnings Date | Feb 25, 2021 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 137.11 |
Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, has implemented the first wave of Panorama AI innovations following the breakthrough results shared earlier from the SMART study.
These under-the-radar stocks have had incredible growth over the last 5 years, and are all off over 15% from their highs.
Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in non-invasive genetic testing and analysis of cfDNA, and Tesis Labs, a US multi-region lab services provider with labs in Colorado, Texas and Arizona, announced a strategic partnership in the field of prenatal genetic testing.